NO20071936L - Polymorfer av cysteinproteaseinhibitoren N-(1-cyanosyklopropyl)-3-syklopropylmetansulfonyl-2(R)-(2,2,2-trifluor-1(S)-(4-fluorfenyl)etylamino)propionamid - Google Patents

Polymorfer av cysteinproteaseinhibitoren N-(1-cyanosyklopropyl)-3-syklopropylmetansulfonyl-2(R)-(2,2,2-trifluor-1(S)-(4-fluorfenyl)etylamino)propionamid

Info

Publication number
NO20071936L
NO20071936L NO20071936A NO20071936A NO20071936L NO 20071936 L NO20071936 L NO 20071936L NO 20071936 A NO20071936 A NO 20071936A NO 20071936 A NO20071936 A NO 20071936A NO 20071936 L NO20071936 L NO 20071936L
Authority
NO
Norway
Prior art keywords
polymorphs
cyanocyclopropyl
propionamide
trifluoro
cyclopropylmethanesulfonyl
Prior art date
Application number
NO20071936A
Other languages
English (en)
Inventor
Sheila M Zipfel
Soon H Woo
Donglai Yang
Simon Bates
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/943,768 external-priority patent/US7547701B2/en
Priority claimed from PCT/US2005/033074 external-priority patent/WO2006034006A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20071936L publication Critical patent/NO20071936L/no

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Foreliggende oppfinnelse er rettet mot polymorfer av N-(1-cyansyklopropyl)-3-syklopropylmetansulfonyl2(R)-(2,2,2-trifluor-l(S)-4-fluorfenyletylamino)propionamid, metoder for anvendelse av disse for å behandle en sykdom formidlet av cathepsin S, farmasøytiske preparater omfattende slike polymorfer, og fremgangsmåter for fremstilling av disse.
NO20071936A 2004-09-17 2007-04-16 Polymorfer av cysteinproteaseinhibitoren N-(1-cyanosyklopropyl)-3-syklopropylmetansulfonyl-2(R)-(2,2,2-trifluor-1(S)-(4-fluorfenyl)etylamino)propionamid NO20071936L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/943,768 US7547701B2 (en) 2003-09-18 2004-09-17 Haloalkyl containing compounds as cysteine protease inhibitors
PCT/US2004/030442 WO2005028429A2 (en) 2003-09-18 2004-09-17 Haloalkyl containing compounds as cysteine protease inhibitors
US66424405P 2005-03-21 2005-03-21
PCT/US2005/033074 WO2006034006A1 (en) 2004-09-17 2005-09-16 Polymorphs of the cysteine protease inhibitor n- (1-cyanocyclopropyl)-3-cyclopropylmethansulfonyl-2 (r) - (2,2,2-trifluoro-1 (s) - (4-fluorophenyl) ethylamino) propionamide

Publications (1)

Publication Number Publication Date
NO20071936L true NO20071936L (no) 2007-06-12

Family

ID=38325575

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071936A NO20071936L (no) 2004-09-17 2007-04-16 Polymorfer av cysteinproteaseinhibitoren N-(1-cyanosyklopropyl)-3-syklopropylmetansulfonyl-2(R)-(2,2,2-trifluor-1(S)-(4-fluorfenyl)etylamino)propionamid

Country Status (5)

Country Link
BR (1) BRPI0515449A2 (no)
IL (1) IL181791A0 (no)
MX (1) MX2007003112A (no)
NO (1) NO20071936L (no)
ZA (1) ZA200703104B (no)

Also Published As

Publication number Publication date
ZA200703104B (en) 2008-09-25
IL181791A0 (en) 2007-07-04
BRPI0515449A2 (pt) 2008-12-16
MX2007003112A (es) 2007-05-21

Similar Documents

Publication Publication Date Title
CY1111050T1 (el) Φωσφονικα, μονοφωσφοναμιδικα, διφωσφοναμιδικα για την αγωγη των ιϊκων παθησεων
EA200600588A1 (ru) Соединения, содержащие галоидалкил, как ингибиторы цистеиновых протеаз
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
CY1110214T1 (el) Μεθοδοι και ενδιαμεσα
WO2007075598A3 (en) N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
CY1111212T1 (el) Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ
AP1744A (en) Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
ATE443043T1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
EA200870127A1 (ru) Полициклические производные аминокислот и способы их применения
TW200719892A (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
NO20071937L (no) Fremgangsmater og mellomprodukter for fremstilling av cysteinproteaseinhibitorer
NO20070423L (no) Ny anvendelse av peptidforbindelser for behandling av essensiell tremor og andre tremorsyndromer
MA28176A1 (fr) Inhibiteurs de la forme mutante du kit
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
EA200601223A1 (ru) Производные сульфонамида для лечения заболеваний
NO20075815L (no) Formuleringer og metoder for behandling av amyloidose
EA201201550A1 (ru) Производные альфа-кетоамидов в качестве ингибиторов цистеинпротеаз
EA200601912A1 (ru) Применение пептидных соединений для профилактики и лечения хронической головной боли
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
WO2006023866A3 (en) Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
SE0303480D0 (sv) Benzofuranes
DE602005010421D1 (de) Neue Cysteine Protease Hemmers und ihre therapeutische Anwendungen
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии